tiprankstipranks
Advertisement
Advertisement

Alembic Pharmaceuticals Announces Death of Senior Delhi-Based Director

Story Highlights
  • Alembic Pharmaceuticals reported the sudden death of Saibal Mukherjee, its Delhi Resident Director.
  • The company called his passing a major loss and notified exchanges under listing rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Alembic Pharmaceuticals Announces Death of Senior Delhi-Based Director

Meet Samuel – Your Personal Investing Prophet

Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) has issued an update.

Alembic Pharmaceuticals has announced the death of Mr. Saibal Mukherjee, who served as Resident Director at its Delhi office and had been with the company since 2014. The company described him as an integral part of the organisation and noted that his sudden passing represents a significant loss.

The board and employees have expressed deep sympathy and condolences to Mukherjee’s family, underscoring his importance to Alembic’s leadership team. The disclosure was made under Indian listing regulations to keep investors and exchanges informed about changes in senior management.

More about Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company engaged in developing, manufacturing, and marketing generic formulations and active pharmaceutical ingredients. The company serves domestic and international markets, focusing on regulated markets and a broad portfolio of prescription medicines across multiple therapeutic areas.

Average Trading Volume: 4,527

Technical Sentiment Signal: Sell

Current Market Cap: 147.6B INR

Find detailed analytics on APLLTD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1